A surprising finding of the present study was that osteosarcoma-derived Sema3A inhibited the formation of new ectopic bone in mice inoculated with KHOS cells, contrasting with the osteoanabolic effects of Sema3A in mice reported in previous studies29. Here, SEMA3A is linked to osteosarcoma.